Streetbeat News

Stock Prices

MCD

McDonald's Corporation's Malaysian licensee, Gerbang Alaf Restaurants Sdn Bhd (GAR), has filed a lawsuit against the Boycott, Divestment and Sanctions (BDS) Malaysia movement for defamation, seeking 6 million ringgit ($1.31 million) in damages. BDS Malaysia is accused of making false statements that allegedly led to reduced profits, job cuts, outlet closures, and shortened operating hours for McDonald's in Malaysia. BDS Malaysia has denied the allegations and is leaving the matter to the court. McDonald's stock (MCD) saw a slight increase of 0.07% to $296.73.

Portfolio Pulse from Shivani Kumaresan

January 02, 2024 | 4:06 pm

AMZN

BRK-A

GOOG

META

MSFT

NVDA

ORCL

SPY

TSLA

WMT

The top 10 richest people in the world saw their wealth increase by $465.4 billion in 2023, surpassing Walmart's market cap. The S&P 500's strong performance, with a 24% increase, and the rise in technology stocks contributed to this wealth growth. Elon Musk regained his position as the world's richest person. The SPDR S&P 500 ETF (SPY) was up 24% in 2023. Notable billionaires like Jeff Bezos, Bill Gates, and Mark Zuckerberg also saw significant increases in their wealth.

Portfolio Pulse from Chris Katje

January 02, 2024 | 4:06 pm

CDIO

Cardio Diagnostics' stock is up following the announcement that the American Medical Association has assigned a dedicated CPT PLA code, 0440U, for its PrecisionCHD product.

Portfolio Pulse from Benzinga Newsdesk

January 02, 2024 | 4:03 pm

AUR

Aurora Innovation Inc (NASDAQ:AUR) shares dropped 11.6% to $3.86 after announcing plans to issue securities up to $850 million. The company intends to use the funds for operational needs and potential investments in new technologies or businesses, although no specific agreements are in place. The plans are subject to change based on business conditions, and in the interim, funds may be placed in secure, interest-bearing assets.

Portfolio Pulse from Henry Khederian

January 02, 2024 | 4:03 pm

KNSA

Wedbush analyst David Nierengarten has maintained an Outperform rating on Kiniksa Pharmaceuticals (NASDAQ:KNSA) and increased the price target from $23 to $25.

Portfolio Pulse from Benzinga Newsdesk

January 02, 2024 | 4:01 pm

ASAN

Asana (NYSE:ASAN) has been rated by 7 analysts in the past three months, with a shift towards a more bearish stance in the last 30 days. The average 12-month price target for ASAN is now $19.57, down from $20.25. Analysts from firms including Piper Sandler, Morgan Stanley, Oppenheimer, HSBC, and UBS have adjusted their ratings and price targets, reflecting changes in market conditions and company performance. Asana's financial performance shows a market cap below industry average, revenue growth of 17.72%, but lagging net margin, ROE, and ROA. The company has a conservative debt-to-equity ratio of 0.85.

Portfolio Pulse from Benzinga Insights

January 02, 2024 | 4:00 pm

TGT

Target Corporation (NYSE:TGT) has seen a surge in options activity, with a notable division in sentiment among investors. Benzinga's options scanner detected 17 unusual options activities, with 58% bullish and 41% bearish. The options suggest a targeted price range of $120 to $175 for Target over the last 3 months. The most significant options trades include bearish puts and bullish calls with various expiration dates and strike prices. Target is the sixth-largest retailer in the U.S., with over 1,900 stores and annual sales over $100 billion. The stock price is currently up 0.73% at $143.46, with potential overbought signals from RSI indicators. Target's next earnings report is expected in 56 days.

Portfolio Pulse from Benzinga Insights

January 02, 2024 | 4:00 pm

AUR

Aurora Innovation's stock is trading lower following the company's filing for an $850 million mixed securities shelf offering, which could dilute existing shareholders' equity.

Portfolio Pulse from Benzinga Newsdesk

January 02, 2024 | 4:00 pm

AMD

Advanced Micro Devices (NASDAQ:AMD) is evaluated against competitors in the Semiconductors & Semiconductor Equipment industry. AMD's P/E ratio is significantly higher than the industry average, suggesting a premium valuation. Its P/B ratio is below the industry average, indicating potential undervaluation, while a high P/S ratio might suggest overvaluation based on sales. AMD's ROE is lower than the industry average, hinting at potential inefficiency. The company's EBITDA and gross profit are also below the industry average, and it has a declining revenue growth rate. AMD's lower debt-to-equity ratio compared to top peers suggests a stronger financial position.

Portfolio Pulse from Benzinga Insights

January 02, 2024 | 4:00 pm

ADBE

Adobe (NASDAQ:ADBE) received mixed ratings from 15 analysts in the past three months, with an average 12-month price target of $658.33, up 5.82% from the previous target. Analysts from firms like Piper Sandler, Barclays, and Citigroup have raised their price targets, reflecting a positive outlook on Adobe's performance. Adobe's financial indicators such as revenue growth, net margin, ROE, ROA, and debt management are strong compared to industry averages.

Portfolio Pulse from Benzinga Insights

January 02, 2024 | 4:00 pm